JPRN-UMIN000004332
Completed
Phase 1
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer. - Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.
Tokyo Women's Medical University0 sites20 target enrollmentOctober 6, 2010
ConditionsPancreatic cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pancreatic cancer
- Sponsor
- Tokyo Women's Medical University
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Pregnancy or lactation 2\.Decision of unsuitableness by principal investigatior 3\.Patient with severe underlying disease 4\.Patient with severe allergy disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
Completed
Phase 2
A phase II trial of postoperative adjuvant chemotherapy with carboplatin/ docetaxel for the patients completely resected Non Small Cell Lung Cancernon-small cell lung cancerJPRN-UMIN000002425niversity of Occupational and Environmental Health65
Completed
Not Applicable
A randomized phase II trial of postoperative adjuvant therapy with imanitib for 1 Year versus 6 months in patients with gastrointestinal stromal tumorsGastrointestinal stromal tumor (GIST)JPRN-UMIN000000950Kinki GIST Study Group80
Recruiting
Not Applicable
Feasibility study of postoperative adjuvant therapy using S-1 after curative esophagectomy for esophageal cancerJPRN-jRCT1060220042Hirahara Noriyuki45
Recruiting
Not Applicable
A Phase I/II Trial of combined adjuvant therapy with gemcitabine and cisplatin for resected biliary tract cancerResected biliary tract cancerJPRN-UMIN000004359Shinshu University School of Medicine, Surgery33